Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Biomedical Nanotechnology|May 23, 2015
Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicityManu M Joseph, S R Aravind, Suraj K George, et al.
ACS Biomaterials Science & Engineering|January 18, 2021
Tracking the Footprints of Paclitaxel Delivery and Mechanistic Action via SERS Trajectory in Glioblastoma CellsJyothi B Nair, Saswat Mohapatra, Manu M Joseph, et al.
ACS Applied Bio Materials|January 13, 2022
Endogenous H<sub>2</sub>S-Assisted Cancer-Cell-Specific Activation of Theranostics with Emission ReadoutKondapa Naidu Bobba, Giridharan Saranya, Palasseri T Sujai, et al.
Biosensors & Bioelectronics|February 19, 2022
NADH-depletion triggered energy shutting with cyclometalated iridium (III) complex enabled bimodal Luminescence-SERS sensing and photodynamic therapyShanmughan Shamjith, Manu M Joseph, Vishnu Priya Murali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2021
Dynamic self-assembly of mannosylated-calix[4]arene into micelles for the delivery of hydrophobic drugsPadincharapad Sreedevi, Jyothi B Nair, Manu M Joseph, et al.
Journal of Biochemical and Molecular Toxicology|July 21, 2017
Bisindole-oxadiazole hybrids, T3P<sup>®</sup> -mediated synthesis, and appraisal of their apoptotic, antimetastatic, and computational Bcl-2 binding potentialPooja R Kamath, Manu M Joseph, Abdul Ajees Abdul Salam, et al.
International Journal of Biological Macromolecules|December 5, 2020
Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicinB S Unnikrishnan, Anitha Sen, G U Preethi, et al.
Pageof 6